Written and maintained by CASRAI Editorial Board
Published · Last updated
This page describes products and general use; it is not medical advice.
On this page
A transcutaneous oxygen monitor is a noninvasive, heated skin sensor that tracks changes in the oxygen tension at the skin surface. Clinic staff, biomedical and procurement teams, and students use this page to see how the FDA classifies the device and which regulatory facts to confirm with a supplier before a purchase.
What a transcutaneous oxygen monitor is
The FDA’s regulation calls the device a cutaneous oxygen (PcO2) monitor. Under 21 CFR 868.2500 it is “a noninvasive, heated sensor (e.g., a Clark-type polargraphic electrode) placed on the patient’s skin that is intended to monitor relative changes in the cutaneous oxygen tension.” “Transcutaneous” and “cutaneous” name the same measurement site: the skin. The abbreviations PcO2 and TcPO2 refer to the same measurement.
Who uses it: the FDA files the device in its Anesthesiology panel. Facilities that already work with hyperbaric or wound-care equipment will find it mentioned in the hyperbaric chamber facility supply checklist.
How it is built
The regulation describes two defining features. The sensor is heated, and it sits on the skin rather than in the body or the bloodstream. The regulation gives a Clark-type electrode as an example of the sensing element. The words “relative changes” matter: the regulatory definition describes monitoring changes in cutaneous oxygen tension, and does not describe reporting arterial blood gas values. For comparison with another monitoring device class, see the EMS monitor guide.
Types and variants
The FDA’s product classification database lists two product codes under the same regulation. Both are Class II and sit in the Anesthesiology panel.
| FDA product code | FDA device name | Class | Regulation |
|---|---|---|---|
| KLK | Monitor, oxygen, cutaneous, for infant not under gas anesthesia | 2 | 21 CFR 868.2500 |
| LPP | Monitor, oxygen, cutaneous, for uses other than for infant not under gas anesthesia | 2 | 21 CFR 868.2500 |
The split is by intended use: code KLK covers infants not under gas anesthesia, and LPP covers other uses. A supplier’s labelling should say which use the device is intended for.
How the FDA regulates it, and what to verify
The regulation sets out three facts that shape a supplier conversation:
- Class II (special controls). The special control is FDA’s guidance document “Class II Special Controls Guidance Document: Cutaneous Carbon Dioxide (PcCO2) and Oxygen (PcO2) Monitors; Guidance for Industry and FDA.” Ask the supplier how the product addresses it.
- Exempt from 510(k), with limits. The device is exempt from premarket notification “subject to the limitations in § 868.9.” An exemption is not the same as having no FDA classification, and a missing K number does not by itself mean a problem. For K numbers, read the FDA K number guide and FDA clearance vs approval.
- Intended use. Confirm that the product code, regulation number (868.2500) and intended-use statement on the labelling match what your team will use it for.
Your own product evaluation record can capture these answers; see the medical product evaluation form.
Common mistakes
- Treating the device as an arterial blood gas analyser. The regulation describes monitoring relative changes in cutaneous oxygen tension.
- Assuming that “510(k) exempt” means unregulated. The device is Class II with a named special control.
- Using different names for the same device (transcutaneous, cutaneous, PcO2, TcPO2) in a request for quotation, which makes supplier documents hard to compare.
Frequently asked questions
Is a transcutaneous oxygen monitor FDA regulated?
Yes. It is a Class II device under 21 CFR 868.2500, with FDA’s PcCO2 and PcO2 monitor guidance as its special control. It is exempt from 510(k) premarket notification subject to the limits in 21 CFR 868.9.
What is the difference between product codes KLK and LPP?
Both are Class II under 21 CFR 868.2500. KLK is “Monitor, oxygen, cutaneous, for infant not under gas anesthesia” and LPP is “Monitor, oxygen, cutaneous, for uses other than for infant not under gas anesthesia.”
What does the FDA call it?
“Cutaneous oxygen (PcO2) monitor.” Product codes KLK and LPP carry the device name “Monitor, oxygen, cutaneous.”
Is the sensor heated?
Yes. The FDA’s definition describes a noninvasive, heated sensor placed on the patient’s skin.
Sources
- eCFR, 21 CFR 868.2500 Cutaneous oxygen (PcO2) monitor, ecfr.gov, text current to the 2026-10-29 issue, checked 2026-11-01.
- FDA Product Classification database and openFDA device classification records for product codes KLK and LPP, accessdata.fda.gov, checked 2026-11-01.







